Ross Levine
Vermogen: 1 M $ op 31-07-2026
Vermogen: 1 M $ op 31-07-2026
Ross L.
Levine is the founder of Ajax Therapeutics, Inc., founded in 2019, serving as Director since its founding.
Current jobs include Independent Director at Medicus Sciences Acquisition Corp.
since 2021; Member of the Supervisory Board at QIAGEN NV since 2016; Member of the Supervisory Board at QIAGEN GmbH; Professor at Weill Cornell Medical College since 2007; and Member of the Supervisory Board at QIAGEN Srl.
Former jobs include Chief of Molecular Cancer Medicine Services at Memorial Sloan Kettering Cancer Center from 2018 to 2022 and Scientific Advisor at eFFECTOR Therapeutics, Inc. Education includes a doctorate from The Johns Hopkins University School of Medicine and an undergraduate degree from Harvard College.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
QIAGEN NV 0,01% | 23-01-2026 | 27.495 ( 0,01% ) | 1 M $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MEDICUS SCIENCES ACQUISITION CORP. | Directeur/Bestuurslid | 12-02-2021 |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services Provides products for preanalytical sample preparation and molecular diagnostics solutions | Directeur/Bestuurslid | - |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-2007 |
Qiagen SRL
Qiagen SRL Medical SpecialtiesHealth Technology Provides molecular testing solutions | Directeur/Bestuurslid | - |
Ajax Therapeutics, Inc.
Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics | Oprichter | 01-01-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
| QIAGEN N.V. | Directeur/Bestuurslid | 23-01-2026 |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Corporate Officer/Principal | - |
| EFFECTOR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 10 |
|---|---|
QIAGEN NV
QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Health Services |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services Provides products for preanalytical sample preparation and molecular diagnostics solutions | Commercial Services |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Qiagen SRL
Qiagen SRL Medical SpecialtiesHealth Technology Provides molecular testing solutions | Health Technology |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ajax Therapeutics, Inc.
Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics | Commercial Services |
Medicus Sciences Acquisition Corp.
Medicus Sciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau